摘要:
The invention relates to methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid (3APS) in a subject, preferably a human subject. The invention encompasses compounds that will yield or generate 3APS, either in vitro or in vivo. Preferred compounds include amino acid prodrugs of 3APS for use, including but not limited to, the prevention and treatment of Alzheimer's disease.
摘要:
Amines are prepared from an olefin and ammonia or a primary and/or secondary amine in the presence of a zeolite catalyst of the pentasil type. Iron silicate zeolites of the pentasil type having an SiO.sub.2 /Fe.sub.2 O.sub.3 ratio greater than or equal to 10 are preferably used.
摘要翻译:胺在戊烯型沸石催化剂存在下由烯烃和氨或初级和/或仲胺制备。 优选使用SiO 2 / Fe 2 O 3比例大于或等于10的pentasil型铁硅酸盐沸石。
摘要:
Alkylamines are produced by reacting an alcohol with an amino compound, especially ammonia, using a catalyst containing nickel and/or cobalt and at least one difficulty reducible metal oxide, e.g. alumina, particularly alumina plus a rare earth, and having a high nickel/cobalt content.
摘要:
Molded catalyst materials contain metallic cobalt and/or nickel particles and a lubricant, the said particles being obtained by reduction of cobalt oxide and/or nickel oxide particles containing less than 0.1% by weight of alkali metal oxides and/or alkaline earth metal oxides at .ltoreq.500.degree. C., and the molded catalyst material having an indentation hardness greater than 300 kp/cm.sup.2.
摘要:
A method of forming transparent electrodes using printable conductive ink containing conductive materials dispersed in a viscous liquid which upon printing and thermal treatment will vaporise fully leaving behind the conductive material only. The viscous liquid acts as a medium by which conductive material dispersions are made processable for use in various printing techniques, allowing conductive patterns to be printed onto substrates (e.g. plastics, glass, metals, ceramics).
摘要:
The present invention relates to a binder for the production of bonded mineral wool, wherein a phenol-formaldehyde-binder is applied onto the still hot fibers after the fiberization of a mineral wool, using a binder that comprises hydroxylamine or an amino alcohol with the following general formula (I) wherein R1 and R2 are the same or different from each other, and independently are hydrogen, a linear or branched, saturated or unsaturated aliphatic hydrocarbon with 1-12 carbon atoms, a saturated or unsaturated alicyclic or heterocyclic hydrocarbon with 5-8 carbon atoms, a carbocyclic or heterocyclic aromatic hydrocarbon with 5-12 ring members or a chain-like or branched alkylether with 1-50 alkoxy units or a chain-like or branched alkylamine with 1-50 alkylamine units; and R3 is a linear or branched, saturated or unsaturated aliphatic hydrocarbon with 1-12 carbon atoms, a saturated or unsaturated alicyclic or heterocyclic hydrocarbon with 5-8 carbon atoms, a carbocyclic or heterocyclic aromatic hydrocarbon with 5-12 ring members or a chain-like or branched alkylether with 1-50 alkoxy units or a chain-like or branched alkylamine with 1-50 alkylamine units.
摘要:
A method of producing NH2(R2), the method comprising reacting a metal hydride with a compound having the general formula: M1X(BH4)y(NH2(R2))n wherein M1 comprises one or more of Li, Na, K, Rb, Cs, Be, Mg, Ca, Sr, Ba, La, Al, Ga and Sc; 0
摘要:
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
摘要:
The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
摘要:
Storage-stable blocked polyisocyanates prepared by reacting one or more polyisocyanates with one or more biuretizing agents and optionally, catalysts such that in the blocked end product there are 5-45 equivalent percent of biuret groups according to formula (I) based on the sum total of all free and blocked NCO groups; optionally modifying the resulting biuret polyisocyanates with the aid of isocyanate-reactive compounds and/or catalysts, with further reaction of free NCO groups; and subsequently blocking at least 95 mol percent of the remaining free NCO groups with a blocking agent according to the formula R1R2NH, where R1 and R2 independently of one another are aliphatic or cycloaliphatic C1-C12 alkyl radicals. The blocked polyisocyanates can be used to make polyurethane polymers and coating compositions, which can be used to coat substrates.